Home LiteratureArticle Details
PMID: 7532677 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.

The Journal of experimental medicine ·Vol. 181 ·No. 3 ·1995-03-01 ·Pages 1133-44

Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P

Abstract

Although inhibition of natural killer (NK) cell-mediated lysis by the class I HLA molecules of target cells is an established phenomenon, knowledge of the features of class I molecules which induce this effect remains rudimentary. Using class I alleles HLA-B*1502 and B*1513 which differ only at residues 77-83 which define the Bw4 and Bw6 serological epitopes, we tested the hypothesis that the presence of the Bw4 epitope on class I molecules determines recognition by NKB1+ NK cells. HLA-B*1513 possesses the Bw4 epitope, whereas B*1502 has the Bw6 epitope. Lysis by NKB1+ NK cell clones of transfected target cells expressing B*1513 as the only HLA-A, -B, or -C molecule was inhibited, whereas killing of transfectants expressing B*1502 was not. Addition of an an anti-NKB1 monoclonal antibody reconstituted lysis of the targets expressing B*1513, but did not affect killing of targets bearing B*1502. The inhibitory effect of B*1513 could be similarly prevented by the addition of an anti-class I monoclonal antibody. These results show that the presence of the Bw4 epitope influences recognition of HLA-B molecules by NK cells that express NKB1, and suggest that the NKB1 molecule may act as a receptor for Bw4+ HLA-B alleles. Sequences outside of the Bw4 region must also affect recognition by NKB1+ NK cells, because lysis of transfectants expressing HLA-A*2403 or A*2501, which possess the Bw4 epitope but are in other ways substantially different from HLA-B molecules, was not increased by addition of the anti-NKB1 antibody. Asparagine 86, the single site of N-linked glycosylation on class I molecules, is in close proximity to the Bw4/Bw6 region. The glycosylation site of the Bw4-positive molecule B*5801 was mutated, and the mutant molecules tested for inhibition of NKB1+ NK cells. Inhibition that could be reversed by addition of the anti-NKB1 monoclonal antibody was observed, showing the presence of the carbohydrate moiety is not essential for class I recognition by NKB1+ NK cell clones.

MeSH Terms
Adult Amino Acid Sequence Animals Base Sequence Bone Marrow Transplantation/immunology Carbohydrates/physiology Epitopes Graft Rejection HLA-B Antigens/chemistry,genetics,immunology Humans Killer Cells, Natural/immunology Mice Mice, Inbred BALB C Molecular Sequence Data Receptors, Immunologic/analysis,physiology Structure-Activity Relationship
Chemicals
Carbohydrates Epitopes HLA-B Antigens HLA-Bw4 antigen Receptors, Immunologic
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Gumperz J E
Department of Microbiology & Immunology, Stanford University, California 94305.
Litwin V
Phillips J H
Lanier L L
Parham P
References (47)
47 references, click to expand
  1. HLA-B specificities and w4, w6 specificities are on the same polypeptide.
    Eur J Immunol. 1976 Nov;6(11):794-9 PMID: 63373
  2. The HLA-B73 antigen has a most unusual structure that defines a second lineage of HLA-B alleles.
    Tissue Antigens. 1994 May;43(5):302-13 PMID: 7524186
  3. Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells.
    Proc Natl Acad Sci U S A. 1980 Jul;77(7):4251-5 PMID: 6933474
  4. Biosynthesis and cell surface localization of nonglycosylated human histocompatibility antigens.
    J Immunol. 1981 Jan;126(1):270-5 PMID: 7005335
  5. The free and the beta 2-microglobulin-associated heavy chains of HLA-A, B alloantigens share the antigenic determinant recognized by the monoclonal antibody Q1/28.
    Immunogenetics. 1981;13(4):285-95 PMID: 6168579
  6. Monoclonal antibodies: purification, fragmentation and application to structural and functional studies of class I MHC antigens.
    J Immunol Methods. 1982 Sep 17;53(2):133-73 PMID: 6183363
  7. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens.
    J Immunol. 1983 Oct;131(4):1789-96 PMID: 6225799
  8. Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones.
    J Immunol Methods. 1984 Aug 3;72(1):219-27 PMID: 6086760
  9. A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus.
    Mol Cell Biol. 1985 Feb;5(2):410-3 PMID: 2983194
  10. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.
    Nature. 1986 Feb 20-26;319(6055):675-8 PMID: 3951539
  11. The primary structure of HLA-A32 suggests a region involved in formation of the Bw4/Bw6 epitopes.
    J Immunol. 1986 Dec 1;137(11):3671-4 PMID: 2431040
  12. Amino acid sequences in the alpha 1 domain and not glycosylation are important in HLA-A2/beta 2-microglobulin association and cell surface expression.
    Mol Cell Biol. 1987 Mar;7(3):982-90 PMID: 3550437
  13. Public epitopes and the antigenic structure of the HLA molecules.
    Crit Rev Immunol. 1987;7(3):229-67 PMID: 2441930
  14. Structure of the human class I histocompatibility antigen, HLA-A2.
    Nature. 1987 Oct 8-14;329(6139):506-12 PMID: 3309677
  15. Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes.
    Proc Natl Acad Sci U S A. 1989 Apr;86(7):2361-4 PMID: 2784569
  16. Demonstration by class I gene transfer that reduced susceptibility of human cells to natural killer cell-mediated lysis is inversely correlated with HLA class I antigen expression.
    Eur J Immunol. 1989 Mar;19(3):447-51 PMID: 2707298
  17. Genetic and serological heterogeneity of the supertypic HLA-B locus specificities Bw4 and Bw6.
    Immunogenetics. 1989;30(3):200-7 PMID: 2777338
  18. Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice.
    Science. 1989 Nov 3;246(4930):666-8 PMID: 2814488
  19. Biology of natural killer cells.
    Adv Immunol. 1989;47:187-376 PMID: 2683611
  20. The alpha 1/alpha 2 domains of class I HLA molecules confer resistance to natural killing.
    J Immunol. 1989 Dec 1;143(11):3853-7 PMID: 2479694
  21. Comparison of class I MHC alleles in humans and apes.
    Immunol Rev. 1990 Feb;113:147-85 PMID: 1690682
  22. Recognition of an HLA public determinant (Bw4) by human allogeneic cytotoxic T lymphocytes.
    J Immunol. 1990 Jun 1;144(11):4172-6 PMID: 2341716
  23. Expression of T cell antigen receptor heterodimers in a lipid-linked form.
    Science. 1990 Aug 10;249(4969):677-9 PMID: 1696397
  24. Chromosomal location of the Ly-49 (A1, YE1/48) multigene family. Genetic association with the NK 1.1 antigen.
    J Immunol. 1990 Oct 1;145(7):2353-8 PMID: 1975828
  25. Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2.
    Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):5989-92 PMID: 2068075
  26. Identification of self peptides bound to purified HLA-B27.
    Nature. 1991 Sep 26;353(6342):326-9 PMID: 1922338
  27. Hybrid resistance in vitro. Possible role of both class I MHC and self peptides in determining the level of target cell sensitivity.
    J Immunol. 1992 Apr 1;148(7):2307-13 PMID: 1545133
  28. Murine natural killer cells and marrow graft rejection.
    Annu Rev Immunol. 1992;10:189-213 PMID: 1590985
  29. Reptilian class I major histocompatibility complex genes reveal conserved elements in class I structure.
    Immunogenetics. 1992;36(3):166-74 PMID: 1612650
  30. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells.
    Nature. 1992 Jul 2;358(6381):66-70 PMID: 1614533
  31. Peptide-induced modulation of target cell sensitivity to natural killing.
    J Immunol. 1992 Aug 15;149(4):1185-90 PMID: 1500711
  32. Role for major histocompatibility complex class I in regulating natural killer cell-mediated killing of virus-infected cells.
    Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8337-41 PMID: 1325654
  33. Molecular analysis of the association of HLA-B53 and resistance to severe malaria.
    Nature. 1992 Dec 3;360(6403):434-9 PMID: 1280333
  34. Peptide motifs of HLA-B35 and -B37 molecules.
    Immunogenetics. 1993;38(2):161-2 PMID: 8482580
  35. Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C.
    Science. 1993 May 21;260(5111):1121-4 PMID: 8493555
  36. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities.
    J Exp Med. 1993 Aug 1;178(2):597-604 PMID: 8340759
  37. Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type.
    J Exp Med. 1993 Oct 1;178(4):1321-36 PMID: 8376937
  38. Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs.
    Immunogenetics. 1994;39(1):74-7 PMID: 8225441
  39. Allele-specific peptide ligand motifs of HLA-C molecules.
    Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):12005-9 PMID: 8265661
  40. Peptide binding to major histocompatibility complex molecules.
    Annu Rev Cell Biol. 1993;9:163-206 PMID: 7506551
  41. Ly-49 mediates EL4 lymphoma adhesion to isolated class I major histocompatibility complex molecules.
    J Exp Med. 1994 Mar 1;179(3):1011-5 PMID: 8113669
  42. Structural heterogeneity in HLA-B70, a high-frequency antigen of black populations.
    Tissue Antigens. 1993 Nov;42(5):509-17 PMID: 8146861
  43. HLA-B73: an atypical HLA-B molecule carrying a Bw6-epitope motif variant and a B pocket identical to HLA-B27.
    Immunogenetics. 1994;40(2):166 PMID: 7517915
  44. NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules.
    J Exp Med. 1994 Aug 1;180(2):537-43 PMID: 8046332
  45. HLA-B15: a widespread and diverse family of HLA-B alleles.
    Tissue Antigens. 1994 Apr;43(4):209-18 PMID: 7521976
  46. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80.
    J Exp Med. 1994 Oct 1;180(4):1235-42 PMID: 7931060
  47. The structure and evolution of the HLA--Bw4 and Bw6 antigens.
    Tissue Antigens. 1979 May;13(5):334-41 PMID: 91209
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1995-03-01
Pages
1133-44
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2191933
Subset
IM
Grants
NIAID NIH HHS · AI-22039 · United States
NIGMS NIH HHS · GM-07276 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]